NCT01711125View on ClinicalTrials.gov

Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Alcoholic Liver DiseaseAlcohol Dependence
Interventions
DRUG

Baclofen 30mg/day

30mg/day 10 mg t.i.d

DRUG

Baclofen 75mg/day

75mg/day 25 mg t.i.d

DRUG

Placebo

Placebo 3 matched tabs/day

Trial Locations (1)

2050

Drug Health Services, Royal Prince Alfred Hospital, Sydney

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

University of Sydney

OTHER

lead

South West Sydney Local Health District

OTHER

NCT01711125 - Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease | Biotech Hunter | Biotech Hunter